Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN23209146) titled 'Clinical outcomes for patients diagnosed with renal cancer and caval thrombus involvement considering surgery' on July 7.
Study Type: Observational
Study Design:
Multicenter registry study (Diagnostic, Quality of life, Treatment, Safety, Efficacy)
Primary Sponsor: Imperial College Healthcare NHS Trust
Condition:
Renal cell carcinoma with inferior vena cava thrombus involvement
Cancer
Intervention:
IR1-CAVALThromb is a prospective, multicenter, registry study. The researchers plan to invite several centers to the register. They will collect data on patients who undergo radical nephrectomy with caval thrombec...